On this basis, we performed functional experiments, confirming that the DNA-binding activity of ATF1 was selectively higher in the BRCA1-mutated cancer cells compared to the sporadic ones and it correlated inversely with the expression of gelsolin, independently on the protein levels of the cAMP response element-binding protein/activating transcription factor. This evidence concerns the gene GSN and cancer.